5th International Conference on Rare Diseases and Orphan Drugs
Theme : Advancing Rare Disease Research: From Scientific Discovery to Innovative Therapies and Global Patient Care
Theme : Advancing Rare Disease Research: From Scientific Discovery to Innovative Therapies and Global Patient Care
November 30, 2026
November 30, 2026
September 15, 2027
October 15, 2027
Coalesce Research Group is pleased to announce the 5th International Conference on Rare Diseases and Orphan Drugs, set to take place on October 14-15, 2027, in Paris, France. This two-day conference serves as a global platform for researchers, clinicians, and industry experts to discuss recent advancements, challenges, and opportunities in the field of rare diseases and orphan drugs
The Rare Diseases and Orphan Drugs 2027 conference brings together researchers, clinicians, healthcare professionals, pharmaceutical experts, and academicians to discuss recent advances in rare disease research, diagnosis, and treatment.
The conference aims to encourage scientific collaboration, share emerging research findings, and explore innovative approaches to orphan drug development, precision medicine, gene therapy, and patient care. It will provide a platform for presenting original research, clinical studies, and case reports while addressing current challenges and future directions in rare disease science.
Aim and Objectives
To promote research collaboration, encourage scientific exchange, and support advances in rare disease diagnosis, therapeutic development, and patient-centered care.
Target Audience
Researchers, clinicians, medical specialists, pharmaceutical scientists, biotechnology professionals, public health experts, academicians, and clinical research professionals.
Who Can Attend?
Quick Links
Supported Journals
The Rare Disease and Orphan Drugs Journal (RDODJ)
The Rare Disease and Orphan Drugs Journal (RDODJ) is an international, peer-reviewed, open-access journal published quarterly by OAE Publishing Inc. RDODJ is indexed in ESCI, Scopus, Dimensions, Lens, and ASCI. The journal received its first Impact Factor of 1.9 in 2026 and has a 2025 CiteScore of 2.1. The Editor-in-Chief is Prof. Daniel Scherman (Paris University, Fondation Maladies Rares). RDODJ is dedicated to advancing research across the multidisciplinary and interdisciplinary field of rare diseases and orphan drugs.
The journal reports on scientific advances in the genetics of rare diseases, molecular basis of rare disease pathologies, and translational research in diagnosis, prevention, and treatment. In addition, RDODJ aims to provide a forum for scientific studies and discussion covering the important regulatory, socio-economic and human science issues related to rare diseases and orphan drugs. The ultimate objective of RDODJ is to promote the dissemination of research results and scientific discussion among the research community, practitioners, and patient-advocacy organizations.
Journal of Translational Genetics and Genomics
The Journal of Translational Genetics and Genomics is an open access international journal promoting the translation of basic research into clinical practice. The aims of the journal are to publish high quality, original, peer-reviewed research articles of discoveries in the area of genetics and genomics. Coverage extends, but not limited to, the basic and clinical studies related to human genetics including molecular and clinical genetics, biochemistry, molecular signaling, epigenetics, pharmaceutical sciences, pharmacogenomics, molecular biology, pharmacology and oncology. The journal also emphasizes on the development of clinical potential and application of new therapeutics, disease-specific biomarkers, cellular and molecular medicine, bioinformatics, artificial intelligence, drug application, and health policy. Manuscript of interest on clinical implications for the prevention and treatment of diseases will be given preference.
The article types include original research, review, meta-analysis, systematic review, technical notes, commentary, letter to editor, opinion, perspective and editorial.
University of Western Australia
Australia
City of Scientific Research and Technological Applications SRTA-City
Egypt
The 4th International Conference on Rare Diseases and Orphan Drugs, scheduled for October 22-23, 2026, at the Hotel Best Front Maritim, Barcelona, Spain, with the theme "From Discovery to Delivery: Translating Rare Disease Science into Global Impact," featured an amalgamation of outstanding speakers who enlightened the attendees with their knowledge related to the field of rare diseases and orphan drugs.
The conference hosted by Coalesce Research Group was marked by the attendance of renowned and brilliant researchers, business delegates, and talented student communities representing more than 20 countries around the world.
The meeting began with an opening ceremony, followed by keynote sessions and a series of lectures (Oral & Posters) delivered by honorable guests and members of the keynote forum. The highlights of the meeting were the eponymous lectures, delivered by:
The two-day event implanted a firm relation of upcoming strategies in this field. We are thankful to all our organizing committee, speakers & students for encouraging and supporting us to conduct the conference and workshops and catapulting the same to the pinnacle of success.
If you have any feedback for us for future consideration or enhancements to this conference, please provide your feedback to the Conference Manager, Sarah Alexandra, at rarediseases@crgconferences.org
We wish to see you all at our next event scheduled for October 14 - 15, 2027, in Paris, France
To know more about our upcoming conferences, kindly click: https://crgconferences.com/rarediseases/
Brochure
Abstract
Program
Registration
